Vertex Pharmaceuticals Incorporated (VRTX) Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C
5/1/2013 7:23:50 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the quarter ended March 31, 2013. The company also today increased its KALYDECO net revenue guidance for 2013 and reiterated other components of financial guidance, as provided on January 29, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by